GLP-1 receptor agonists are a gamechanger in obesity care, but researchers are still working to better understand their ...

The thriving market in online, counterfeit GLP-1 drugs that do not meet FDA criteria poses serious risks to consumers.

GLP-1 drugs like Wegovy alone do not work, may benefit more from a combination treatment, a recent review of the evidence ...

GLP-1 medications may not always work for weight loss. New research suggests that around 10% of people carry genetic ...

Learn how new oral GLP-1 weight loss pills work, how they compare with injections, and how next-gen “small molecule” drugs ...

While taking a GLP-1, certain behaviours can worsen side effects or inhibit the benefits you receive. Here's what to avoid.

A majority of people who start the obesity and diabetes medicines known as GLP-1s also quit them, and plan to restart again.

Insurance coverage for GLP-1 medications like Ozempic and Wegovy varies widely depending on the condition and your plan.

Researchers at Toronto's Sinai Health have found that semaglutide—the active ingredient in popular weight loss drugs that ...

Variants in GLP‑1 and GIP receptor genes partly determine weight loss and nausea risk on GLP‑1 drugs, signaling a shift from ...